Anti-clotting drug gets FDA priority review

02/22/2008 | Reuters

The FDA has granted priority review to an anti-clotting drug from Daiichi Sanyko Co. Ltd. and Eli Lilly and Co. The pill, prasugrel, could compete with Plavix if approved.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA